PubMed

Intralesional lymphokine-activated killer cells as adjuvant therapy for primary glioblastoma.

Dillman RO, Duma CM, Ellis RA, Cornforth AN, Schiltz PM, Sharp SL, DePriest MC.

J Immunother. 2009 Nov-Dec;32(9):914-9.PMID: 19816190 [PubMed - in process]Related articles

Developing an effective lung cancer program in a community hospital setting.

Fischel RJ, Dillman RO.

Clin Lung Cancer. 2009 Jul;10(4):239-43.PMID: 19632940 [PubMed - in process]Related articles

Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final report.

Dillman RO, Selvan SR, Schiltz PM, McClay EF, Barth NM, DePriest C, de Leon C, Mayorga C, Cornforth AN, Allen K.

Cancer Biother Radiopharm. 2009 Jun;24(3):311-9.PMID: 19538053 [PubMed - indexed for MEDLINE]Related articles

Increases in serum TARC/CCL17 levels are associated with progression-free survival in advanced melanoma patients in response to dendritic cell-based immunotherapy.

Cornforth AN, Lee GJ, Fowler AW, Carbonell DJ, Dillman RO.

J Clin Immunol. 2009 Sep;29(5):657-64. Epub 2009 May 7.PMID: 19421847 [PubMed - in process]Related articles

Surgical resection and long-term survival for octogenarians who undergo surgery for non-small-cell lung cancer.

Dillman RO, Zusman DR, McClure SE.

Clin Lung Cancer. 2009 Mar;10(2):130-4.PMID: 19362957 [PubMed - indexed for MEDLINE]Related articles

Identification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance.

Dillman RO, Aaron K, Heinemann FS, McClure SE.

Cancer. 2009 May 1;115(9):1840-8.PMID: 19208427 [PubMed - indexed for MEDLINE]Related articles

Unique aspects of supportive care using monoclonal antibodies in cancer treatment.

Dillman RO, Hendrix CS.

Support Cancer Ther. 2003 Oct 1;1(1):38-48.PMID: 18628130 [PubMed - in process]Related articlesFree article

Abstracting height and weight from medical records, and breast cancer pathologic factors.

McEligot AJ, Im T, Dillman RO, West JG, Salem R, Haque R, Anton-Culver H.

Cancer Causes Control. 2008 Dec;19(10):1217-26. Epub 2008 Jul 10.PMID: 18618281 [PubMed - indexed for MEDLINE]Related articles

Lack of elevation of serum S100B in patients with metastatic melanoma as a predictor of outcome after induction with an autologous vaccine of proliferating tumor cells and dendritic cells.

Schiltz PM, Dillman RO, Korse CM, Cubellis JM, Lee GJ, De Gast GC.

Cancer Biother Radiopharm. 2008 Apr;23(2):214-21.PMID: 18454690 [PubMed - indexed for MEDLINE]Related articles

Monoclonal antibodies in cancer therapy: 25 years of progress.

Oldham RK, Dillman RO.

J Clin Oncol. 2008 Apr 10;26(11):1774-7. No abstract available. PMID: 18398141 [PubMed - indexed for MEDLINE]Related articles

Immunophenotyping of chronic lymphoid leukemias.

Dillman RO.

J Clin Oncol. 2008 Mar 10;26(8):1193-4. No abstract available. PMID: 18323542 [PubMed - indexed for MEDLINE]Related articles

Human allogeneic and murine xenogeneic dendritic cells are cytotoxic to human tumor cells via two distinct pathways.

Schiltz PM, Lee GJ, Zhang JG, Hoa N, Wepsic HT, Dillman RO, Jadus MR.

Cancer Biother Radiopharm. 2007 Oct;22(5):672-83.PMID: 17979570 [PubMed - indexed for MEDLINE]Related articles

Monitoring response to treatment in melanoma patients: potential of a serum glycomic marker.

Selvan SR, Dillman RO, Fowler AW, Carbonell DJ, Ravindranath MH.

Int J Cancer. 2008 Mar 15;122(6):1374-83.PMID: 17960619 [PubMed - indexed for MEDLINE]Related articles

Patient-specific vaccines derived from autologous tumor cell lines as active specific immunotherapy: results of exploratory phase I/II trials in patients with metastatic melanoma.

Dillman RO, DePriest C, DeLeon C, Barth NM, Schwartzberg LS, Beutel LD, Schiltz PM, Nayak SK.

Cancer Biother Radiopharm. 2007 Jun;22(3):309-21.PMID: 17651037 [PubMed - indexed for MEDLINE]Related articles

Community-based phase II trial of pentostatin, cyclophosphamide, and rituximab (PCR) biochemotherapy in chronic lymphocytic leukemia and small lymphocytic lymphoma.

Dillman RO, Schreeder MT, Hon JK, Connelly EF, DePriest C, Cutter K.

Cancer Biother Radiopharm. 2007 Apr;22(2):185-93.PMID: 17600465 [PubMed - indexed for MEDLINE]Related articles

Improving survival for patients with breast cancer compared with intramural and extramural benchmarks.

Dillman RO, McClure SE.

Clin Breast Cancer. 2007 Feb;7(6):480-5.PMID: 17386125 [PubMed - indexed for MEDLINE]Related articles

Patient-specific dendritic-cell vaccines for metastatic melanoma.

Dillman RO, Selvan SR, Schiltz PM.

N Engl J Med. 2006 Sep 14;355(11):1179-81. No abstract available. PMID: 16971731 [PubMed - indexed for MEDLINE]Related articles

Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer.

Nemunaitis J, Dillman RO, Schwarzenberger PO, Senzer N, Cunningham C, Cutler J, Tong A, Kumar P, Pappen B, Hamilton C, DeVol E, Maples PB, Liu L, Chamberlin T, Shawler DL, Fakhrai H.

J Clin Oncol. 2006 Oct 10;24(29):4721-30. Epub 2006 Sep 11.PMID: 16966690 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of subcutaneous interferon followed by intravenous hybrid bolus/continuous infusion interleukin-2 in the treatment of renal cell carcinoma: final results of Cancer Biotherapy Research Group 95-09.

Dillman RO, Wiemann MC, Tai DF, Depriest CB, Soori G, Stark JJ, Mahdavi K, Church CK.

Cancer Biother Radiopharm. 2006 Apr;21(2):130-7.PMID: 16706633 [PubMed - indexed for MEDLINE]Related articles

Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies.

Dillman RO.

Clin Exp Med. 2006 Mar;6(1):1-12. Review.PMID: 16550338 [PubMed - indexed for MEDLINE]Related articles

Lymphocyte therapy of renal cell carcinoma.

Dillman RO.

Expert Rev Anticancer Ther. 2005 Dec;5(6):1041-51. Review.PMID: 16336095 [PubMed - indexed for MEDLINE]Related articles

Cancer vaccine potency: is there a dose/response relationship for patient-specific vaccines and clinical outcomes?

Dillman RO, Beutel L, Nayak S, Depriest C, Selvan S, Schiltz P.

Cancer Biother Radiopharm. 2005 Aug;20(4):373-8.PMID: 16114985 [PubMed - indexed for MEDLINE]Related articles

American Society of Clinical Oncology 41st annual meeting.

Dillman RO.

Expert Opin Biol Ther. 2005 Aug;5(8):1117-27. Review.PMID: 16050788 [PubMed - indexed for MEDLINE]Related articles

High-dose chemotherapy and autologous stem cell rescue for metastatic breast cancer: superior survival for tandem compared with single transplants.

Dillman RO, Barth NM, VanderMolen LA, Allen K, Beutel LD, Chico S.

Am J Clin Oncol. 2005 Jun;28(3):281-8.PMID: 15923802 [PubMed - indexed for MEDLINE]Related articles

International Society for Biological Therapy for Cancer: 20th anniversary.

Dillman RO.

J Immunother. 2005 May-Jun;28(3):169-74. No abstract available. PMID: 15838372 [PubMed - indexed for MEDLINE]Related articles

Establishment and characterization of a human primary prostate carcinoma cell line, HH870.

Selvan SR, Cornforth AN, Rao NP, Reid YA, Schiltz PM, Liao RP, Price DT, Heinemann FS, Dillman RO.

Prostate. 2005 Apr 1;63(1):91-103.PMID: 15468172 [PubMed - indexed for MEDLINE]Related articles

Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma.

Dillman RO, Duma CM, Schiltz PM, DePriest C, Ellis RA, Okamoto K, Beutel LD, De Leon C, Chico S.

J Immunother. 2004 Sep-Oct;27(5):398-404.PMID: 15314549 [PubMed - indexed for MEDLINE]Related articles

Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity.

Socinski MA, Zhang C, Herndon JE 2nd, Dillman RO, Clamon G, Vokes E, Akerley W, Crawford J, Perry MC, Seagren SL, Green MR.

Ann Oncol. 2004 Jul;15(7):1033-41.PMID: 15205196 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum cytokines in metastatic melanoma patients treated with an autologous tumor vaccine.

Schiltz PM, Dillman RO.

Cancer Biother Radiopharm. 2003 Dec;18(6):879-86.PMID: 14969600 [PubMed - indexed for MEDLINE]Related articles

Pentostatin (Nipent) in the treatment of chronic lymphocyte leukemia and hairy cell leukemia.

Dillman RO.

Expert Rev Anticancer Ther. 2004 Feb;4(1):27-36. Review.PMID: 14748654 [PubMed - indexed for MEDLINE]Related articles

How can we improve survival rate for patients with non-small-cell lung cancer?

Dillman RO.

Clin Lung Cancer. 2000 Nov;2(2):152. No abstract available. PMID: 14731328 [PubMed]Related articlesFree article

Treatment of human solid malignancies with autologous activated lymphocytes and cimetidine: a phase II trial of the cancer biotherapy research group.

Dillman RO, Soori G, DePriest C, Nayak SK, Beutel LD, Schiltz PM, de Leon C, O'Connor AA.

Cancer Biother Radiopharm. 2003 Oct;18(5):727-33.PMID: 14629821 [PubMed - indexed for MEDLINE]Related articles

Treatment of low-grade B-cell lymphoma with the monoclonal antibody rituximab.

Dillman RO.

Semin Oncol. 2003 Aug;30(4):434-47. Review.PMID: 12939712 [PubMed - indexed for MEDLINE]Related articles

Radioimmunotherapy of relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.

Dillman RO.

Curr Hematol Rep. 2003 Jan;2(1):30-7. Review.PMID: 12901152 [PubMed - indexed for MEDLINE]Related articles

Interferon-gamma or granulocyte-macrophage colony-stimulating factor administered as adjuvants with a vaccine of irradiated autologous tumor cells from short-term cell line cultures: a randomized phase 2 trial of the cancer biotherapy research group.

Dillman RO, Wiemann M, Nayak SK, DeLeon C, Hood K, DePriest C.

J Immunother. 2003 Jul-Aug;26(4):367-73.PMID: 12843799 [PubMed - indexed for MEDLINE]Related articles

Does continuous-infusion interleukin-2 increase survival in metastatic melanoma?

Dillman RO, O'Connor AA, Simpson L, Barth NM, VanderMolen LA, Vanderplas P.

Am J Clin Oncol. 2003 Apr;26(2):141-5.PMID: 12714884 [PubMed - indexed for MEDLINE]Related articles

Radiolabeled anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoma.

Dillman RO.

J Clin Oncol. 2002 Aug 15;20(16):3545-57. Review. No abstract available. PMID: 12177115 [PubMed - indexed for MEDLINE]Related articles

16th Annual Scientific Meeting of the Society for Biological Therapy. 8 - 11 November 2001, Bethesda, Maryland, USA.

Dillman RO, Dillman JB.

Expert Opin Biol Ther. 2002 Feb;2(2):223-7.PMID: 12170947 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of subcutaneous interleukin-2, subcutaneous interferon-alpha, 5-fluorouracil and cis-retinoic acid in the treatment of renal cell carcinoma: final results of cancer biotherapy research group 94-10.

Soori G, Dillman RO, Wiemann MC, Stark JJ, Tai F, DePriest CB, Church CK, Schulof R.

Cancer Biother Radiopharm. 2002 Apr;17(2):165-73.PMID: 12030110 [PubMed - indexed for MEDLINE]Related articles

Radioimmunotherapy for non-Hodgkin's lymphoma with yttrium 90 ibritumomab tiuxetan.

Hendrix CS, de Leon C, Dillman RO.

Clin J Oncol Nurs. 2002 May-Jun;6(3):144-8.PMID: 11998607 [PubMed - indexed for MEDLINE]Related articles

Irradiated cells from autologous tumor cell lines as patient-specific vaccine therapy in 125 patients with metastatic cancer: induction of delayed-type hypersensitivity to autologous tumor is associated with improved survival.

Dillman RO, Beutel LD, Barth NM, de Leon C, O'Connor AA, DePriest C, Nayak SK.

Cancer Biother Radiopharm. 2002 Feb;17(1):51-66.PMID: 11915174 [PubMed - indexed for MEDLINE]Related articles

Successful treatment of transitional cell carcinoma of the urethra with chemotherapy.

VanderMolen LA, Sheehy PF, Dillman RO.

Cancer Invest. 2002;20(2):206-7. No abstract available. PMID: 11901541 [PubMed - indexed for MEDLINE]Related articles

Monoclonal antibody therapy for lymphoma: an update.

Dillman RO.

Cancer Pract. 2001 Mar-Apr;9(2):71-80.PMID: 11879282 [PubMed - indexed for MEDLINE]Related articles

Characterization of human tumor-infiltrating lymphocytes expanded in hollow-fiber bioreactors for immunotherapy of cancer.

Malone CC, Schiltz PM, Mackintosh AD, Beutel LD, Heinemann FS, Dillman RO.

Cancer Biother Radiopharm. 2001 Oct;16(5):381-90.PMID: 11776755 [PubMed - indexed for MEDLINE]Related articles

Monoclonal antibodies in the treatment of malignancy: basic concepts and recent developments.

Dillman RO.

Cancer Invest. 2001;19(8):833-41. Review.PMID: 11768037 [PubMed - indexed for MEDLINE]Related articles

The history and rationale for monoclonal antibodies in the treatment of hematologic malignancy.

Dillman RO.

Curr Pharm Biotechnol. 2001 Dec;2(4):293-300. Review.PMID: 11762411 [PubMed - indexed for MEDLINE]Related articles

Utilization of breast-conserving surgery in breast cancer.

Dillman RO, Chico S, Finestone S.

J Clin Oncol. 2001 Dec 1;19(23):4350-1. No abstract available. PMID: 11731521 [PubMed - indexed for MEDLINE]Related articles

15th Annual Scientific Meeting of the Society for Biological Therapy. 26-29 October 2000, Seattle, Washington, USA.

Dillman RO.

Expert Opin Biol Ther. 2001 Jan;1(1):129-34.PMID: 11727542 [PubMed - indexed for MEDLINE]Related articles

Short-term tumor cell lines from breast cancer for use as autologous tumor cell vaccines in the treatment of breast cancer.

Dillman RO, Beutel LD, De Leon C, Nayak SK.

Cancer Biother Radiopharm. 2001 Jun;16(3):205-11.PMID: 11471485 [PubMed - indexed for MEDLINE]Related articles

Short-term autologous tumor cell lines for the active specific immunotherapy of patients with metastatic melanoma.

Dillman RO, DeLeon C, Beutel LD, Barth NM, Schwartzberg LS, Spitler LE, Garfield DH, O'Connor AA, Nayak SK.

Crit Rev Oncol Hematol. 2001 Jul-Aug;39(1-2):115-23.PMID: 11418308 [PubMed - indexed for MEDLINE]Related articles